Analytical testing, QC

Three Ways to Leverage AI in Clinical Trials Right Now

Three Ways to Leverage AI in Clinical Trials Right Now

Content provided by Saama

White Paper

the exponential growth of data points flowing into clinical study databases. As technologies help researchers to reach more patients all over the world, the amount of data that requires monitoring, formatting, and analysis will only increase over time.

dPCR Case Study

dPCR Case Study

Content provided by CellCarta

Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring your adoptive cell therapy (ACT) meets safety regulations relating to VCN and RCL/RCR levels, even...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

Content provided by CellCarta

Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed to address specific therapeutic development requirements and provide the most highly customized...

Maximizing Drug Formulation for First-In-Human Trials

Maximizing Drug Formulation for First-In-Human Trials

Content provided by Altasciences

Case Study

The manufacture of a drug product for clinical trials is of critical importance. The formulation, manufacturing, and assessment of a drug candidate during first-in-human (FIH) trials can be contributing factors in whether the drug safely provides the...

INDENA’S CUSTOM DEVELOPMENT AND MANUFACTURING SERVICES FOR APIS AND HPAPIS

INDENA’S CUSTOM DEVELOPMENT AND MANUFACTURING SERVICES FOR APIS AND HPAPIS

Content provided by Indena

White Paper

Indena’s Custom Development & Manufacturing Organization services offers a full range of manufacturing capabilities for pharmaceutical ingredients. Such services include the extraction, isolation and purification of natural derivatives and the process R&D...

Advanced Analytics Driving Interactive Data Exploration in Study Teams

Advanced Analytics Driving Interactive Data Exploration in Study Teams

Content provided by PerkinElmer

White Paper

At Novartis, TIBCO Spotfire® enterprise analytics is a key tool for interactive graphical data analysis for preclinical and clinical studies. Using interactive graphical data exploration provides an efficient, powerful, and flexible tool to improve...

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Content provided by Clinical Ink

White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO) in conjunction with agile methodology enables nimble, efficient clinical data management...

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Content provided by Oracle Health Sciences

White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but today it can come from sources as varied as sensors, smartphones, and electronic health records...

The impact of PAT tools for aseptic manufacturing processes

The impact of PAT tools for aseptic manufacturing processes

Content provided by Telstar Life Science Solutions

Case Study

Telstar case study. What is the impact of leading-edge innovative developments on the process analytical technology field for pharmaceutical systems and aseptic manufacturing processes? Discover how PAT Tools can easily help in the daily pharmaceutical...

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Content provided by Frontage Laboratories

White Paper

Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed, proteins, given their chemistry, are the “most structurally complex and functionally sophisticated...

How to Avoid Surprises in Small-Molecule Drug Development Programs

How to Avoid Surprises in Small-Molecule Drug Development Programs

Content provided by Frontage Laboratories

White Paper

Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent of Phase III studies failed due to safety (compared to 55 percent for efficacy), down from 21...

Validating The Simoa Technology

Validating The Simoa Technology

Content provided by Frontage Laboratories

White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used in bioanalysis—such as Gas Chromatography (GC), High Performance Liquid Chromatography (HPLC), and...

The Truth about Physician Referrals and Clinical Trials

The Truth about Physician Referrals and Clinical Trials

Content provided by BBK Worldwide

White Paper

Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their patients to the investigator. BBK Worldwide’s Study Voices survey challenges the myth, invoking a...

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Content provided by Frontage Laboratories

White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and small molecules – from early phase through to and including post approval. It should be treated as...